STRS Ohio’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

STRS Ohio’s Portfolio GEVA Stock Details GEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-1,700	Closed	-$165K	–	2045
2015 Q1	$165K	Buy	1,700 +1,000	+143%	+$106K	﹤0.01%	1517
2014 Q4	$65K	Sell	700 -12,200	-95%	-$963K	﹤0.01%	1592
2014 Q3	$887K	Sell	12,900 -200	-2%	-$14.3K	﹤0.01%	815
2014 Q2	$1.37M	Buy	+13,100	New	+$1.11M	0.01%	649

STRS Ohio's GEVA Position: Q2 2015 in Review

STRS Ohio sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 1,700 shares — an estimated $165K sold.

STRS Ohio first reported a position in GEVA in Q2 2014 and held it in 4 quarters. The position peaked at $1.37M in Q2 2014. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

STRS Ohio reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
STRS Ohio sold 1,700 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $165K.
STRS Ohio first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q2 2014 and held it in 4 quarters.
STRS Ohio's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $1.37M in Q2 2014.
0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on STRS Ohio's 13F filing for Q2 2015, filed 4 Aug 2015.